Bausch + Lomb: Solid 2024 Results, But Let's Address The Elephant In The Room
BLCO may be sold in 2025 to service the debt of majority shareholder BHC, and any sale will be at a premium to the current ...
Teva Pharma and Alvotech launch biosimilar to J&J's Stelara in US
Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug ...